CVAC

CureVac N.V. Ordinary Shares (CVAC)

About CureVac N.V. Ordinary Shares (CVAC)

CureVac BV is a clinical-stage biopharmaceutical company, which engages in developing transformative medicines based on messenger ribonucleic acid (mRNA). Its product portfolio includes clinical and preclinical candidates across multiple disease indications in prophylactic vaccines, oncology, and protein therapy. The company was founded by Ingmar Hoerr and Florian von der Mülbe in 2000 and is headquartered in Tübingen, Germany.

Details

Daily high
$3.76
Daily low
$3.58
Price at open
$3.71
52 Week High
$5.28
52 Week Low
$2.22
Market cap
803.0M
Dividend yield
0.00%
Volume
9,670
Avg. volume
668,625
P/E ratio
6.51

CureVac N.V. Ordinary Shares News

Details

Daily high
$3.76
Daily low
$3.58
Price at open
$3.71
52 Week High
$5.28
52 Week Low
$2.22
Market cap
803.0M
Dividend yield
0.00%
Volume
9,670
Avg. volume
668,625
P/E ratio
6.51